Cargando…
Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation
BACKGROUND: Varicella zoster virus (VZV) is one of the eight known human herpesviruses. Initial VZV infection results in chickenpox, while viral reactivation following a period of latency manifests as shingles. Separate vaccines exist to protect against both initial infection and subsequent reactiva...
Autores principales: | Bakker, Kevin M, Eisenberg, Marisa C, Woods, Robert J, Martinez, Micaela E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548166/ https://www.ncbi.nlm.nih.gov/pubmed/36209074 http://dx.doi.org/10.1186/s12916-022-02534-7 |
Ejemplares similares
-
COVID-19 vaccination may reactivate varicella-zoster virus
Publicado: (2022) -
Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
por: Gershon, Anne A, et al.
Publicado: (2021) -
Varicella zoster virus reactivation and mRNA vaccines as a trigger
por: Lladó, Iñigo, et al.
Publicado: (2021) -
Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine
por: Ilyas, Sahrish, et al.
Publicado: (2020) -
Silent Reactivation of Varicella Zoster Virus in Pregnancy: Implications for Maintenance of Immunity to Varicella
por: Mourad, Mirella, et al.
Publicado: (2022)